MOLECULE HOLDINGS (ERV2) — Financial Flexibility Index

Latest as of October 2022: -0.14x

MOLECULE HOLDINGS (ERV2) has a Financial Flexibility Index of -0.14x as of October 2022. Free cash flow of €-1.10 Million (operating CF €-1.13 Million minus capex €33.11K) represents 0% of total liabilities (€7.61 Million). Also explore ERV2 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.14x
Free Cash Flow / Total Liabilities

Free Cash Flow

€-1.10 Million
Operating CF − Capex

Total Liabilities

€7.61 Million
EUR

Capital Expenditures

€33.11K
EUR

MOLECULE HOLDINGS Financial Flexibility Index (2021–2022)

Historical Financial Flexibility Index trend for MOLECULE HOLDINGS across 2 annual periods. See ERV2 net asset quality index to measure how much of total assets are equity-financed.

Annual Financial Flexibility Index for MOLECULE HOLDINGS (2021–2022)

Year-by-year free cash flow to debt coverage for MOLECULE HOLDINGS. For the full company profile including market capitalisation, see MOLECULE HOLDINGS (ERV2) total market value.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2022 -0.14x €-1.10 Million €-1.13 Million €7.61 Million ▲ +72.6%
2021 -0.53x €-2.79 Million €-2.87 Million €5.32 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities